V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008454 | 280005647 | 1.73 | 50 | Palliative (P) | 2014-09-25 | 2014-09-25 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280027627 | GEMCITABINE |
| 280008455 | 280005647 | 0 | null | Palliative (P) | 2018-02-25 | 2018-03-07 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 280027627 | GEMCITABINE |
| 280008456 | 280005648 | 0 | 75.1 | Palliative (P) | 2017-11-12 | 2017-11-15 | Carboplatin + Etoposide iv&po | 02 | N | 280027631 | CARBOPLATIN + ETOPOSIDE |
| 280008457 | 280010564 | 1.66 | 88.9 | Palliative (P) | 2017-12-19 | 2018-01-19 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 280027635 | CISPLATIN + GEMCITABINE |
| 280008458 | 280005649 | 1.73 | 82.4 | Palliative (P) | 2015-12-14 | 2015-12-19 | Doxorubicin + Olaratumab | N | N | 280027638 | DOXORUBICIN + OLARATUMAB |
| 280008459 | 280005649 | 1.92 | 48.8 | Palliative (P) | 2013-06-08 | 2014-01-18 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | N | 280027638 | CETUXIMAB + CISPLATIN + FU |
| 280008460 | 280005650 | null | null | Curative (C) | 2018-04-13 | 2018-05-02 | Carboplatin + Etoposide IV 3 day | 2 | N | 280027641 | CARBOPLATIN + ETOPOSIDE |
| 280008461 | 280005651 | 1.7 | 26.2 | Neo-adjuvant (N) | 2015-12-08 | 2017-08-21 | Carboplatin + Etoposide IV 3 day | N | N | 280027643 | CARBOPLATIN + ETOPOSIDE |
| 280008462 | 280008964 | 1.65 | 71.6 | Palliative (P) | 2013-05-23 | 2013-06-13 | GEMCITABINE | N | N | 280027646 | GEMCITABINE |
| 280008463 | 280005653 | 1.7 | 72.2 | Palliative (P) | 2015-07-30 | 2015-07-30 | VAC | N | N | 280027649 | CAV |
| 280008464 | 280005655 | 1.85 | 47.1 | Palliative (P) | 2014-08-30 | 2014-09-12 | Carboplatin + Etoposide iv&po | 02 | N | 280027653 | CARBOPLATIN + ETOPOSIDE |
| 280008465 | 280008965 | 1.76 | null | Palliative (P) | 2015-05-01 | 2015-05-08 | DE-ESCALATE TRIAL | null | N | 280027657 | DE-ESCALATE TRIAL |
| 280008466 | 280008965 | 1.69 | 53.4 | Palliative (P) | null | 2017-07-27 | Doxorubicin + Ifosfamide | N | N | 280027657 | DOXORUBICIN + IFOSFAMIDE |
| 280008467 | 280011724 | 1.54 | null | Palliative (P) | 2018-03-05 | 2018-03-05 | VAC | 02 | null | 280027660 | CAV |
| 280008468 | 280005656 | 1.68 | 61.1 | Palliative (P) | 2018-03-29 | 2018-04-05 | DE-ESCALATE TRIAL | 02 | N | 280027663 | DE-ESCALATE TRIAL |
| 280008469 | 280005657 | 1.77 | 40.4 | Curative (C) | 2015-02-22 | 2015-02-22 | Doxorubicin + Ifosfamide | N | N | 280027663 | DOXORUBICIN + IFOSFAMIDE |
| 280008470 | 280005658 | 1.78 | 82.9 | null | 2016-03-10 | 2016-03-27 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 280027668 | CARBOPLATIN + PACLITAXEL |
| 280008471 | 280005659 | 1.67 | null | Palliative (P) | 2018-05-09 | 2018-05-10 | Oxaliplatin + Modified de Gramont | null | null | 280027677 | OXALIPLATIN + MDG |
| 280008472 | 280008969 | 1.68 | 75 | null | 2013-10-27 | 2013-12-25 | CISPLATIN + FLUOROURACIL | N | Y | 280027678 | CISPLATIN + FLUOROURACIL |
| 280008473 | 280008969 | 1.79 | null | Palliative (P) | 2014-02-06 | 2014-02-06 | CAV | N | N | 280027678 | CAV |
| 280008474 | 280005660 | 1.58 | 66 | Neo-adjuvant (N) | null | 2017-10-04 | EW EuroEwing 99 : VIDE | N | N | 280027682 | EURO-EWING |
| 280008475 | 280005662 | 1.6 | null | Neo-adjuvant (N) | 2015-09-19 | 2015-09-22 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | N | 280027684 | CETUXIMAB + CISPLATIN + FU |
| 280008476 | 280005664 | 1.78 | 63 | Adjuvant (A) | 2018-05-30 | 2018-05-30 | CISPLATIN + FLUOROURACIL | 02 | null | 280027692 | CISPLATIN + FLUOROURACIL |
| 280008477 | 280008972 | 1.73 | 63.2 | null | 2016-02-23 | 2016-03-02 | Cisplatin +Fluorouracil (3 wk) | N | N | 280027698 | CISPLATIN + FLUOROURACIL |
| 280008478 | 280010567 | 1.71 | 58.6 | Palliative (P) | 2014-11-14 | 2014-11-17 | EW Rel rEECur Irinotecan/Temozolomide | null | null | 280027706 | IRINOTECAN + TEMOZOLOMIDE |
| 280008479 | 280005667 | 1.88 | 85.7 | null | 2017-07-31 | 2017-09-02 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 280027711 | CETUXIMAB + CISPLATIN + FU |
| 280008480 | 280005668 | 1.8 | 78.7 | Neo-adjuvant (N) | 2015-04-01 | 2015-04-07 | Cisplatin+Gemcitabine (gallbladder) | 02 | null | 280027711 | CISPLATIN + GEMCITABINE |
| 280008481 | 280005668 | 1.7 | 73.2 | Curative (C) | 2016-02-17 | 2016-02-17 | VAC | 2 | N | 280027711 | CAV |
| 280008482 | 280005669 | 1.74 | 92.5 | Palliative (P) | null | 2014-04-23 | Doxorubicin + Olaratumab | N | N | 280027717 | DOXORUBICIN + OLARATUMAB |
| 280008483 | 280005669 | 1.72 | null | Neo-adjuvant (N) | null | 2017-02-13 | VAI (Ifos 3g/m2) | null | null | 280027717 | IRINOTECAN + MDG |
| 280008484 | 280005670 | 1.79 | 60.7 | null | 2016-03-07 | 2016-03-07 | ETOPOSIDE + IFOSFAMIDE | N | N | 280027722 | ETOPOSIDE + IFOSFAMIDE |
| 280008485 | 280008975 | 1.78 | 61.1 | null | 2017-06-30 | 2017-07-19 | Doxorubicin + Ifosfamide | 2 | N | 280027728 | DOXORUBICIN + IFOSFAMIDE |
| 280008486 | 280005671 | null | null | Palliative (P) | null | 2017-04-28 | IRINOTECAN + MDG | null | null | 280027738 | IRINOTECAN + MDG |
| 280008488 | 280005673 | 1.71 | 56.6 | Neo-adjuvant (N) | 2018-05-14 | 2018-05-21 | VAI (Ifos 3g/m2) | N | N | 280027748 | IRINOTECAN + TEMOZOLOMIDE |
| 280008489 | 280005677 | 1.56 | 70.5 | Palliative (P) | 2015-01-26 | 2015-03-07 | CISPLATIN + GEMCITABINE | N | N | 280027748 | CISPLATIN + GEMCITABINE |
| 280008490 | 280005677 | 1.62 | 105 | Neo-adjuvant (N) | 2017-10-09 | 2017-11-20 | Etoposide + Ifosfamide (3 days) | null | null | 280027748 | ETOPOSIDE + IFOSFAMIDE |
| 280008491 | 280010571 | 1.73 | null | Neo-adjuvant (N) | 2016-04-14 | 2016-05-07 | Etoposide + Ifosfamide (3 days) | 2 | N | 280027757 | ETOPOSIDE + IFOSFAMIDE |
| 280008492 | 280005681 | 1.66 | 85 | Curative (C) | 2017-03-04 | 2017-03-26 | CISPLATIN + FLUOROURACIL | 2 | N | 280027762 | CISPLATIN + FLUOROURACIL |
| 280008493 | 280005684 | 1.85 | 84.7 | Neo-adjuvant (N) | 2017-03-14 | 2017-03-20 | CISPLATIN + GEMCITABINE | 2 | N | 280027763 | CISPLATIN + GEMCITABINE |
| 280008494 | 280005685 | 1.66 | null | Palliative (P) | 2017-01-25 | 2017-01-25 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 280027764 | CETUXIMAB + CISPLATIN + FU |
| 280008495 | 280008979 | 1.61 | null | Palliative (P) | 2013-08-22 | 2013-08-23 | CISPLATIN + FLUOROURACIL | 2 | N | 280027766 | CISPLATIN + FLUOROURACIL |
| 280008496 | 280005687 | 1.55 | 41.5 | Neo-adjuvant (N) | null | 2015-11-19 | Irinotecan + Modified De Gramont | null | null | 280027768 | VAI |
| 280008497 | 280005689 | 1.58 | 57.4 | null | 2017-09-21 | 2017-10-13 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280027776 | GEMCITABINE |
| 280008498 | 280005692 | 1.68 | 65.6 | Curative (C) | 2016-09-27 | 2016-10-06 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280027776 | CARBOPLATIN + PACLITAXEL |
| 280008499 | 280008984 | null | null | Neo-adjuvant (N) | 2015-12-09 | 2016-01-14 | Irinotecan + Temozolomide | N | N | 280027795 | IRINOTECAN + TEMOZOLOMIDE |
| 280008500 | 280008984 | null | 104.7 | Curative (C) | 2017-08-26 | 2017-10-02 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280027795 | CARBOPLATIN + PACLITAXEL |
| 280008501 | 280005696 | null | 55 | null | 2016-12-29 | 2017-02-02 | Cyclophosphamide oral | N | N | 280027804 | CYCLOPHOSPHAMIDE |
| 280008502 | 280008986 | 1.86 | 139.4 | Neo-adjuvant (N) | 2016-12-22 | 2016-12-22 | EW EuroEwing 99 : VActI | 2 | N | 280027815 | EURO-EWING |
| 280008503 | 280005697 | 1.73 | 68.8 | Palliative (P) | 2014-12-03 | 2014-12-03 | Irinotecan + Modified De Gramont | null | Y | 280027817 | VAI |
| 280008504 | 280005701 | null | null | Curative (C) | 2014-09-28 | 2014-10-16 | Cyclophosphamide oral | N | N | 280027820 | CYCLOPHOSPHAMIDE |